News

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, ...
A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...
Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...
Comedians have long used jokes to raise awareness of serious problems, and many are now turning the gaze to climate change.
As we honor Counseling Awareness Month, Relief Mental Health recognizes the critical role that therapy plays in helping ...
The trailer for Season 27 of South Park has been released, and the animated satirical sitcom appears to have a new target: Elon Musk. Newsweek has reached out to X outside of normal working hours via ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
The trailer for the 27th series of South Park has dropped and it appears to include a few swipes at Elon Musk, in regards to ...
Those who have lost a loved one to the opioid epidemic were invited to buy a carnation and drop it in the Sydenham River in ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... in March 2019 and is administered as a nasal spray twice a week for four weeks.
I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...
Neurelis, Inc., today announced details of three poster presentations at the American Academy of Neurology (AAN) Annual ...